116815 ⎘
Hydrolases acting on peptide bonds, i.e. peptidases (3.4); Serine endopeptidases (3.4.21) Chymotrypsin (3.4.21.1)
COMPOSITIONS AND METHODS RELATING TO RECOMBINANT CHYMOTRYPSIN
#2CRYSTALLISATION OF A PROTEIN CAPABLE OF CRYSTALLIZING UNDER SALTING-IN CONDITIONS USING MULTIPLE PROTEIN FEEDS
#3ENZYME BASED COMPOSITIONS AND METHODS FOR REMOVING DENTAL CALCULI
#4SYNTHESIS OF SELF-ASSEMBLING ARTIFICIAL PROTEINS UTILIZING A HOST-GUEST SYSTEM AND USES THEREOF
#5COMPOSITIONS AND METHODS FOR REMOVING DENTAL CALCULI
#6ENZYME BASED COMPOSITIONS AND METHODS FOR REMOVING DENTAL CALCULI
#7PRECISION DELIVERY OF MULTI-SCALE PAYLOADS TO TISSUE-SPECIFIC TARGETS IN PLANTS
#8CANCER TREATMENT
#9ENZYME DELIVERY SYSTEMS AND METHODS OF PREPARATION AND USE
#10NUTRITIVE COMPOSITIONS WITH BIOACTIVE PROTEINS
#11TUNEABLE DELIVERY OF NANOPARTICLE BOUND ACTIVE PLASMIN FOR THE TREATMENT OF THROMBOSIS
#12PURIFIED FISH PROTEASES WITH HIGH SPECIFIC ACTIVITIES AND ITS PROCESS OF PRODUCTION
#13COMPOSITIONS AND METHODS FOR REMOVING DENTAL CALCULI
#14BETA-CASEIN ANALYSIS OF MILK AND MILK PRODUCTS
#15METHOD FOR PREPARING PEPTIDE FRAGMENTS, METHOD FOR PREPARING PROTEASE TO BE USED THEREIN, AND KIT FOR PREPARING PEPTIDE FRAGMENTS
#16Amino-reactive positively charged ATRP initiators that maintain their positive charge during synthesis of biomacro-initiators
#17Generation-dependent supramolecular assemblies of protein-dendron conjugates
#18Method for preparing biomaterial having selectively functionalized tyrosine, biomaterial having selectively functionalized tyrosine, and pharmaceutical composition containing same as active ingredient
#19SOLID-PHASE SYNTHESIS OF PROTEIN-POLYMER CONJUGATES ON IMMOBILIZATION SUPPORTS
#20COMPOSITIONS AND METHODS FOR TREATMENT OR PREVENTION OF STAPHYLOCOCCUS AUREUS INFECTIONS AND FOR THE ERADICATION OR REDUCTION OF STAPHYLOCOCCUS AUREUS ON SURFACES
#21Tuneable delivery of nanoparticle bound active plasmin for the treatment of thrombosis
#22Polymer engineered regenerating bioscavengers
#23Polymer engineered regenerating bioscavengers
#24PROENZYME COMPOSITION
#25Pharmaceutical composition containing a mixture of proenzymes and enzymes
#26Use of electrochemical devices or systems comprising redox-functionalized electrodes for bioseparation and biocatalysis
#27Composition of proenzymes for cancer treatment
#28ZWITTERIONIC POLYMER BIOCONJUGATES AND RELATED METHODS
#29Cancer treatment
#30Enzyme delivery systems and methods of preparation and use
#31Method for Treating Pervasive Development Disorders
#32Method of diagnosing preeclampsia or pregnancy-induced hypertension
#33METHOD FOR QUANTIFYING MONOCLONAL ANTIBODY
#34Methods and compositions for the treatment of symptoms of prion diseases
#35Enzyme formulation for reducing salicylate and other intolerance
#36Process for refolding recombinant chymotrypsin
#37PHARMACEUTICAL PREPARATIONS FOR ATTENTION DEFICIT DISORDER, ATTENTION DEFICIT HYPERACTIVITY DISORDER AND OTHER ASSOCIATED DISORDERS
#38Hydrophobin mimics: process for preparation thereof
#39Tuneable delivery of nanoparticle bound active plasmin for the treatment of thrombosis
#40Adsorbent and method for producing the same
#41Enzyme formulation for reducing salicylate intolerance
#42METHOD FOR TREATING PERVASIVE DEVELOPMENT DISORDERS
#43Serum-free stable transfection and production of recombinant human proteins in human cell lines
#44PHARMACEUTICAL COMPOSITION CONTAINING A MIXTURE OF PROENZYMES AND ENZYMES
#45Method of treating proteinuria in pregnancy
#46Polymer engineered regenerating bioscavengers
#47Methods and compositions for the treatment of symptoms of Williams Syndrome
#48Digestive enzyme composition suitable for enteral administration
#49Polymer-based protein engineering methods to rationally tune enzyme activity, pH-dependence and stability
#50Internalization of proteins into hollowed gold nanostructures
#51Mixture to increase the effectiveness of antiseptics and/or disinfectants, an agent containing the mixture, and the use of this mixture
#52Enzyme delivery systems and methods of preparation and use
#53Milk-derived basic protein fraction as skin sensitivity improving agent
#54Enzyme delivery systems and methods of preparation and use
#55Methods and compositions for the treatment of symptoms of prion diseases
#56Compositions and methods for treatment or prevention of infections and for the eradication or reduction of on surfaces
#57Method of treating pregnancy-induced hypertension
#58Zwitterionic polymer bioconjugates and related methods
#59Enzyme delivery systems and methods of preparation and use
#60Controlled release of biological entities
#61Method of treating and diagnosing Parkinson's disease and related dysautonomic disorders
#62Stabilised protein compositions based on semifluorinated alkanes
#63METHOD FOR DIAGNOSING AND TREATING DYSAUTONOMIA AND OTHER DYSAUTONOMIC CONDITIONS
#64Administration of enzyme and prebiotic combinations that enhance probiotic growth and efficacy
#65Zwitterionic polymer bioconjugates and related methods
#66Method for treating pervasive development disorders
#67Method for treating pervasive development disorders
#68Enzyme Delivery Systems and Methods of Preparation and Use
#69RECOMBINANT PORCINE CHYMOTRYPSIN
#70Method for treating pervasive development disorders
#71Method for treating pervasive development disorders
#72Enzyme delivery systems and methods of preparation and use
#73Protein concentrates and isolates, and processes for the production thereof from toasted oilseed meal
#74Compositions and methods for treatment or prevention of infections and for the eradication or reduction of on surfaces
#75Enzyme delivery systems and methods of preparation and use
#76PROCESS FOR THE HYDROLYSIS OF MILK PROTEINS
#77Serum-free stable transfection and production of recombinant human proteins in human cell lines
#78METHODS AND COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF PRION DISEASES
#79PROCESS FOR PREPARING HYPOALLERGENIC AND/OR NON-ALLERGENIC PEANUT BUTTER AND ASSOCIATED PRODUCTS
#80Methods and compositions for the treatment of symptoms of Williams Syndrome
#81Method for identifying individuals having a pervasive development disorder amenable to digestive enzyme therapy
#82Methods of treating and diagnosing Parkinsons disease and related dysautonomic disorders
#83Controlled release of biological entities
#84Compositions and use thereof for treating symptoms of preeclampsia
#85Method for identifying autistic individuals amenable to digestive enzyme therapy
#86Method for treating pervasive development disorders
#87Process for preparing hypoallergenic and non-allergenic peanuts () utilizing an endopeptidase
#88Methods of treating pervasive development disorders
#89Methods of treating and diagnosing Parkinson's disease and related dysautonomic disorders
#90PHARMACEUTICAL PREPARATIONS FOR ATTENTION DEFICIT DISORDER, ATTENTION DEFICIT HYPERACTIVITY DISORDER AND OTHER ASSOCIATED DISORDERS
#91METHOD OF TREATING AND DIAGNOSING PARKINSONS DISEASE AND RELATED DYSAUTONOMIC DISORDERS
#92One of several enzyme-containing compounds, dietetic food products and drugs produced from and the use therefor for medical purpose
#93Methods for treating pervasive development disorders
#94Methods for treating pervasive development disorders